GlobeNewswire Inc.··NaArcutis to Report Q1 2026 Results as Clinical Data Advances Dermatology Pipeline
Arcutis reports Q1 2026 results May 6 as company presents new Phase 2 pediatric atopic dermatitis data at dermatology conference.
ARQTfinancial resultsclinical trial